Navigation Links
NYU Langone Medical Center researcher named Howard Hughes Investigator
Date:5/9/2013

NEW YORK, May 9, 2013 The Howard Hughes Medical Institute (HHMI) has announced the appointment of Evgeny Nudler, PhD, to the 2013 class of HHMI Investigators.The appointment ranks as one of the highest honors that can be bestowed on a biomedical research scientist. Dr. Nudler, the Julie Wilson Anderson Professor of Biochemistry in the Department of Biochemistry and Molecular Pharmacology at NYU Langone Medical Center, was selected among more than 1,200 applicants for his work on numerous biochemical frontiers, including the role of bacterial gases in antibiotic resistance and the interplay between RNA transcription and the cellular response to stress.

"The depth and breadth of Evgeny Nudler's research is absolutely remarkable," said Dafna Bar-Sagi, PhD, senior vice president and vice dean for science and chief scientific officer at NYU School of Medicine. "The five highly unique projects underway in his lab hold promise for a broad range of diseases, from cancer and heart disease to bacterial infections and Alzheimer's. His versatility and range are invaluable, and his selection as an HMMI Investigator is richly deserved."

Most recently, Dr. Nudler and his colleagues have discovered how the roundworm exploits bacteria within its gut to harness the life-extending benefits of nitric oxide, a gas implicated in a wide range of physiological functions from blood pressure to immune response in mammals. This finding could help unravel the mysteries of human longevity, as our cells may employ a similar biochemical mechanism.

Bacteria cells also exploit nitric oxide for their own purposes, Dr. Nudler has found. In a discovery that sheds light on antibacterial resistance, his team has revealed how the dangerous bacterial species Staphylococcus aureus and Bacillus anthracis manufacture nitric oxide and hydrogen sulfide to guard against oxidative stress and evade many different classes of antibiotics.

Among Dr. Nudler's other scientific contributions, his team was the first to discover bits of RNA present in all life forms that function as molecular circuits to control gene expression. These so-called "riboswitches" are now promising new targets for synthetic molecular switches and antimicrobial therapies. His lab has also developed a suite of biochemical tools to examine how RNA polymerase transcribes RNA from DNA. RNA polymerase is key enzyme of gene regulation and Nudler's work has explained how it moves along DNA, responds to regulatory signals and factors, and terminates transcription. Finally, Dr. Nudler's lab has identified the key biochemical components that allow cells to cope with high temperature and other types of stress that jeopardize the integrity of proteins. A better understanding of these components could lead to therapies that help repair damaged proteins related to cancer and neurodegenerative diseases such as Alzheimer's and Amyotrophic lateral sclerosis (ALS).


'/>"/>

Contact: Lisa Greiner
lisa.greiner@nyumc.org
212-404-3532
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related biology news :

1. St. Jude scientist named Howard Hughes Medical Institute investigator
2. Using bacteria-eaters to prevent infections on medical implant materials
3. Shared Medical Resources, LLC files suit against Histologics, LLC, Womens Health Laboratories and Avero Diagnostics for Willful Patent Infringement
4. BUSM study shows positive impact of mind-body course on well-being of medical students
5. Quest for edible malarial vaccine leads to other potential medical uses for algae
6. New cutting-edge cell research will lead to safer medical experiments on humans
7. PeerJ launches PeerJ PrePrints -- a preprint server for the biological and medical sciences
8. Columbia University Medical Center/NY-Presbyterian experts at AAN
9. CWRU spinoff ConservoCare gets licensing options to develop medical device for bladder control
10. Paving the way for greater use of ancient medical knowledge
11. Sanford-Burnham Medical Research Institute and Mayo Clinic extend collaborative agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder ... local San Diego Rotary Club. The event entitled “Stem Cells and ... had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions ... scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology: